Fujun Yu
Overview
Explore the profile of Fujun Yu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
65
Citations
1323
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zeng Y, Chen Y, Zhu D, Xu J, Zhang X, Ying H, et al.
BMC Cancer
. 2025 Feb;
25(1):220.
PMID: 39920636
Background: Gastric cancer patients are prone to lower extremity deep vein thrombosis (DVT) after surgery, which is an important cause of death in postoperative patients. Therefore, it is particularly important...
2.
Zeng Y, Jiang H, Chen Z, Xu J, Zhang X, Cai W, et al.
Cell Death Dis
. 2025 Jan;
16(1):59.
PMID: 39890782
FOLFOX (5-fluorouracil, oxaliplatin, folinic acid) is a standard treatment for hepatocellular carcinoma, but its efficacy is often limited by drug resistance, the underlying mechanisms of which remain unclear. In this...
3.
Chen Z, Zeng L, Cai W, Song X, Xu Q, Xu J, et al.
Ann Med
. 2024 Dec;
57(1):2443256.
PMID: 39705015
Background: Malnutrition is prevalent in patients with inflammatory bowel disease (IBD); however, its ability to predict the disease activity in IBD remains unexplored. Therefore, this study aimed to explore the...
4.
Ying H, Chen Y, Hong Y, Ying K, Li S, Zhang Y, et al.
Ann Med
. 2024 Dec;
57(1):2440114.
PMID: 39665392
Background: Programmed death ligand-1 (PD-1), as an immunotherapy target, has been increasingly used in tumour therapies. But as reactions and outcomes to PD-1 inhibitors combined with chemotherapy vary individually, it...
5.
Zhang X, Zeng Y, Ying H, Hong Y, Xu J, Lin R, et al.
Ecotoxicol Environ Saf
. 2024 Dec;
289():117511.
PMID: 39662457
AdipoRon has been validated for its ability to reverse liver fibrosis, yet the underlying mechanisms remain to be thoroughly investigated. Collagen, predominantly synthesized and secreted in hepatic stellate cells (HSCs),...
6.
Chen Z, Zeng Y, Ma P, Xu Q, Zeng L, Song X, et al.
Gene
. 2024 Sep;
933:148958.
PMID: 39312983
Background: Hepatocellular carcinoma (HCC) is a highly fatal malignant worldwide. As different expression levels of specific genes can lead to different HCC outcomes, we aimed to develop a gene signature...
7.
Xie Q, Zeng Y, Zhang X, Yu F
Cancer Immunol Immunother
. 2024 Jul;
73(9):171.
PMID: 38954021
In the intricate landscape of the tumor microenvironment, tumor-associated macrophages (TAMs) emerge as a ubiquitous cellular component that profoundly affects the oncogenic process. The microenvironment of hepatocellular carcinoma (HCC) is...
8.
Cai H, Meng Z, Yu F
Crit Rev Oncol Hematol
. 2024 Apr;
197:104361.
PMID: 38626849
Reactive oxidative species (ROS) is a crucial factor in the regulation of cellular biological activity and function, and aberrant levels of ROS can contribute to the development of a variety...
9.
Zhao L, Zhang X, Chen Z, Lai Y, Xu J, Zhou R, et al.
Food Funct
. 2024 Apr;
15(9):4954-4969.
PMID: 38602356
Overdose of Acetaminophen (APAP) is a major contributor to acute liver injury (ALI), a complex pathological process with limited effective treatments. Emerging evidence links lipid peroxidation to APAP-induced ALI. Cynarin...
10.
Chen Z, Zeng L, Chen Z, Xu J, Zhang X, Ying H, et al.
Technol Cancer Res Treat
. 2024 Apr;
23:15330338241241935.
PMID: 38564315
Hepatocellular carcinoma (HCC), partly because of its complexity and high heterogeneity, has a poor prognosis and an extremely high mortality rate. In this study, mRNA sequencing expression profiles and relevant...